222 related articles for article (PubMed ID: 23254434)
1. The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147L.
LaMarre J; Mendes RE; Szal T; Schwarz S; Jones RN; Mankin AS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1173-9. PubMed ID: 23254434
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
Mendes RE; Deshpande LM; Costello AJ; Farrell DJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4656-61. PubMed ID: 22687512
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.
Tewhey R; Gu B; Kelesidis T; Charlton C; Bobenchik A; Hindler J; Schork NJ; Humphries RM
mBio; 2014 May; 5(3):e00894-14. PubMed ID: 24915435
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Linezolid Resistance Among Clinical
Ruiz-Ripa L; Feßler AT; Hanke D; Eichhorn I; Azcona-Gutiérrez JM; Alonso CA; Pérez-Moreno MO; Aspiroz C; Bellés A; Schwarz S; Torres C
Microb Drug Resist; 2021 Feb; 27(2):145-153. PubMed ID: 32456543
[TBL] [Abstract][Full Text] [Related]
5. Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio.
Mendes RE; Deshpande LM; Bonilla HF; Schwarz S; Huband MD; Jones RN; Quinn JP
Antimicrob Agents Chemother; 2013 Jul; 57(7):2923-8. PubMed ID: 23571552
[TBL] [Abstract][Full Text] [Related]
6. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Mendes RE; Deshpande LM; Castanheira M; DiPersio J; Saubolle MA; Jones RN
Antimicrob Agents Chemother; 2008 Jun; 52(6):2244-6. PubMed ID: 18391032
[TBL] [Abstract][Full Text] [Related]
7. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
8. Emergence of cfr-harbouring coagulase-negative staphylococci among patients receiving linezolid therapy in two hospitals in China.
Yang XJ; Chen Y; Yang Q; Qu TT; Liu LL; Wang HP; Yu YS
J Med Microbiol; 2013 Jun; 62(Pt 6):845-850. PubMed ID: 23449871
[TBL] [Abstract][Full Text] [Related]
9. Linezolid dependence in Staphylococcus epidermidis bloodstream isolates.
Pournaras S; Ntokou E; Zarkotou O; Ranellou K; Themeli-Digalaki K; Stathopoulos C; Tsakris A
Emerg Infect Dis; 2013 Jan; 19(1):129-32. PubMed ID: 23260390
[TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.
Arias CA; Vallejo M; Reyes J; Panesso D; Moreno J; Castañeda E; Villegas MV; Murray BE; Quinn JP
J Clin Microbiol; 2008 Mar; 46(3):892-6. PubMed ID: 18174304
[TBL] [Abstract][Full Text] [Related]
11. Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.
Locke JB; Zuill DE; Scharn CR; Deane J; Sahm DF; Denys GA; Goering RV; Shaw KJ
Antimicrob Agents Chemother; 2014 Nov; 58(11):6592-8. PubMed ID: 25155597
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.
Quiles-Melero I; Gómez-Gil R; Romero-Gómez MP; Sánchez-Díaz AM; de Pablos M; García-Rodriguez J; Gutiérrez A; Mingorance J
J Clin Microbiol; 2013 Mar; 51(3):998-1001. PubMed ID: 23269737
[TBL] [Abstract][Full Text] [Related]
13. Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus.
Baos E; Candel FJ; Merino P; Pena I; Picazo JJ
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):325-9. PubMed ID: 23726146
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.
Seral C; Sáenz Y; Algarate S; Duran E; Luque P; Torres C; Castillo FJ
Int J Med Microbiol; 2011 Apr; 301(4):354-8. PubMed ID: 21236728
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
Dortet L; Glaser P; Kassis-Chikhani N; Girlich D; Ichai P; Boudon M; Samuel D; Creton E; Imanci D; Bonnin R; Fortineau N; Naas T
J Antimicrob Chemother; 2018 Jan; 73(1):41-51. PubMed ID: 29092052
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS
Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436
[TBL] [Abstract][Full Text] [Related]
17. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Zhu W; Tenover FC; Limor J; Lonsway D; Prince D; Dunne WM; Patel JB
Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):161-5. PubMed ID: 17393201
[TBL] [Abstract][Full Text] [Related]
18. Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy.
Brenciani A; Morroni G; Pollini S; Tiberi E; Mingoia M; Varaldo PE; Rossolini GM; Giovanetti E
J Antimicrob Chemother; 2016 Feb; 71(2):307-13. PubMed ID: 26472766
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of linezolid-resistant CoNS isolates in Japan.
Takaya A; Kimura A; Sato Y; Ishiwada N; Watanabe M; Matsui M; Shibayama K; Yamamoto T
J Antimicrob Chemother; 2015 Mar; 70(3):658-63. PubMed ID: 25381168
[TBL] [Abstract][Full Text] [Related]
20. Low fitness cost of the multidrug resistance gene cfr.
LaMarre JM; Locke JB; Shaw KJ; Mankin AS
Antimicrob Agents Chemother; 2011 Aug; 55(8):3714-9. PubMed ID: 21646483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
